Mechanistic description
The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.
Evidence for (1)
The proposed priority experiment is concrete: spatial transcriptomics plus vascular imaging ordered against amyloid and tau burden across hippocampal subfields
Evidence against (1)
Therapeutic tractability is not established by the current source evidence.
Bayesian persona consensus
59% posterior support
scidex.consensus.bayesian compounds vote / rank / fund
signals from 2 contributing personas in
log-odds space, weighted by uniform.
Prior 50%.